Holen Sie sich die Stockscreener-App
2.10
1.45%
0.03
Handel nachbörslich:
2.10
Schlusskurs vom Vortag:
$2.07
Offen:
$2.07
24-Stunden-Volumen:
747.70K
Relative Volume:
0.69
Marktkapitalisierung:
$227.50M
Einnahmen:
$27.08M
Nettoeinkommen (Verlust:
$-37.00M
KGV:
-4.0385
EPS:
-0.52
Netto-Cashflow:
$-18.46M
1W Leistung:
+8.81%
1M Leistung:
+35.48%
6M Leistung:
+13.51%
1J Leistung:
+77.97%
1-Tages-Spanne:
$2.07
$2.15
1-Wochen-Bereich:
$1.93
$2.15
52-Wochen-Spanne:
$1.05
$5.17
Aclaris Therapeutics Inc Stock (ACRS) Company Profile
Firmenname
Aclaris Therapeutics Inc
Sektor
Branche
Telefon
484-324-7933
Adresse
701 LEE ROAD, WAYNE, PA
Vergleichen Sie ACRS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACRS
Aclaris Therapeutics Inc
|
2.10 | 224.25M | 27.08M | -37.00M | -18.46M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Aclaris Therapeutics Inc Stock (ACRS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-05-28 | Eingeleitet | Wedbush | Outperform |
| 2025-03-18 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2024-12-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-11-20 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-11-19 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-11-19 | Hochstufung | Jefferies | Hold → Buy |
| 2024-11-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-11-18 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-01-22 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-10-03 | Eingeleitet | Evercore ISI | Outperform |
| 2022-12-14 | Eingeleitet | Stifel | Buy |
| 2022-12-01 | Eingeleitet | Goldman | Buy |
| 2022-10-06 | Eingeleitet | BTIG Research | Buy |
| 2021-07-23 | Fortgesetzt | Jefferies | Buy |
| 2021-06-15 | Eingeleitet | Piper Sandler | Overweight |
| 2021-04-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-10-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-09-06 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-27 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-05-06 | Eingeleitet | SVB Leerink | Outperform |
| 2018-03-28 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-02-09 | Eingeleitet | Guggenheim | Buy |
| 2017-06-16 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2016-11-29 | Eingeleitet | Leerink Partners | Outperform |
| 2016-09-30 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2016-06-10 | Eingeleitet | Guggenheim | Buy |
| 2015-11-02 | Eingeleitet | Citigroup | Buy |
| 2015-11-02 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Aclaris Therapeutics Inc Aktie (ACRS) Neueste Nachrichten
What’s the recovery path for long term holders of Aclaris Therapeutics Inc.Quarterly Earnings Report & High Conviction Buy Zone Alerts - Newser
Will Aclaris Therapeutics Inc. benefit from rising consumer demandJuly 2025 Recap & Fast Moving Market Watchlists - خودرو بانک
Visual analytics tools that track Aclaris Therapeutics Inc. performanceQuarterly Trade Review & High Accuracy Trade Alerts - Newser
Will Aclaris Therapeutics Inc. outperform the market in YEARMarket Activity Recap & Short-Term Swing Trade Alerts - خودرو بانک
Aclaris Therapeutics to Present at Two Investor Conferences in September - MSN
Is Aclaris Therapeutics Inc.’s ROE strong enough2025 Short Interest & Entry and Exit Point Strategies - خودرو بانک
Is Aclaris Therapeutics Inc. likely to announce a buybackQuarterly Performance Summary & Weekly Top Stock Performers List - خودرو بانک
Will Aclaris Therapeutics Inc. face regulatory challenges2025 Short Interest & Weekly Breakout Stock Alerts - خودرو بانک
Can technical indicators confirm Aclaris Therapeutics Inc.’s reversalBear Alert & Low Risk High Win Rate Stock Picks - Newser
Aclaris Therapeutics Inc. recovery potential after sell off2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser
Aclaris Therapeutics Inc. stock outlook for YEARWeekly Profit Recap & AI Optimized Trade Strategies - Newser
Can Aclaris Therapeutics Inc. continue delivering strong returnsJuly 2025 Spike Watch & Long-Term Growth Plans - خودرو بانک
Aclaris Therapeutics Inc. stock momentum explainedJuly 2025 Trends & Free Weekly Chart Analysis and Trade Guides - Newser
How sentiment analysis helps forecast Aclaris Therapeutics Inc.Market Movement Recap & Technical Confirmation Alerts - Newser
Can Aclaris Therapeutics Inc. recover in the next quarterMarket Performance Summary & AI Driven Price Forecasts - Newser
Market reaction to Aclaris Therapeutics Inc.’s recent news2025 Bull vs Bear & Smart Money Movement Tracker - Newser
Will Aclaris Therapeutics Inc. continue its uptrendPortfolio Gains Report & Real-Time Volume Spike Alerts - Newser
What’s the MACD signal for Aclaris Therapeutics Inc.2025 Valuation Update & Daily Profit Maximizing Trade Tips - خودرو بانک
How to escape a deep drawdown in Aclaris Therapeutics Inc.2025 Bull vs Bear & Free Long-Term Investment Growth Plans - Newser
Is Aclaris Therapeutics Inc. stock ready for a breakoutGap Up & Free Technical Confirmation Trade Alerts - Newser
Aclaris at Cantor Global Healthcare: Strategic Pipeline Insights - Investing.com
Forecasting Aclaris Therapeutics Inc. price range with options dataTrade Entry Report & Reliable Price Action Trade Plans - Newser
Using data tools to time your Aclaris Therapeutics Inc. exitJuly 2025 Catalysts & Weekly Setup with ROI Potential - Newser
Volatility clustering patterns for Aclaris Therapeutics Inc.2025 Dividend Review & Fast Momentum Stock Entry Tips - Newser
Real time pattern detection on Aclaris Therapeutics Inc. stock2025 Institutional Moves & Detailed Earnings Play Strategies - Newser
Long term hold vs stop loss in Aclaris Therapeutics Inc.2025 Performance Recap & Free Technical Confirmation Trade Alerts - Newser
Aclaris Therapeutics Inc. stock trendline breakdown2025 Winners & Losers & Verified Technical Signals - Newser
Earnings visualization tools for Aclaris Therapeutics Inc.2025 Institutional Moves & Weekly High Potential Alerts - Newser
Is Aclaris Therapeutics Inc. a speculative investmentStop Loss & Weekly High Conviction Trade Ideas - خودرو بانک
What’s the beta of Aclaris Therapeutics Inc. stockPortfolio Update Report & Verified Short-Term Plans - خودرو بانک
Aclaris Therapeutics Taps Veteran Biotech Leader Roland Kolbeck as New Chief Scientific Officer - MSN
Developing predictive dashboards with Aclaris Therapeutics Inc. dataJuly 2025 Levels & Real-Time Buy Signal Alerts - Newser
Aclaris Therapeutics Inc. stock daily chart insightsGold Moves & High Yield Equity Trading Tips - Newser
Is Aclaris Therapeutics Inc. stock a falling knife or bargain buyJuly 2025 Volume & Expert Curated Trade Setup Alerts - خودرو بانک
Aclaris Therapeutics Inc. Volume Confirms Breakout — Analysts Bullish2025 Retail Activity & Fast Gaining Stock Strategy Reports - beatles.ru
Finanzdaten der Aclaris Therapeutics Inc-Aktie (ACRS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Aclaris Therapeutics Inc-Aktie (ACRS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mehra Anand | Director |
Nov 19 '24 |
Buy |
2.25 |
666,666 |
1,499,998 |
710,030 |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):